Yifeng Pharmacy Chain Co., Ltd.
603939
Rank in Stocks
#3633
Yifeng Pharmacy Chain Co., Ltd. serves as a key distributor of pharmaceutical... Yifeng Pharmacy Chain Co., Ltd. serves as a key distributor of pharmaceutical goods across China. As of March 31, 2021, the company oversaw an expansive network of approximately 6,279 retail pharmacies. These establishments are strategically situated throughout various significant Chinese provinces and municipalities, including Hunan, Hubei, Shanghai, Jiangsu, Zhejiang, Jiangxi, Guangdong, Hebei, and Beijing. The firm was founded in 2001 and has its primary corporate office located in Changsha, China.
Share Price
$3.84
Market Cap
$4.65B
Change (1 day)
2.73%
Change (1 year)
8.86%
Country
CN
Trade Yifeng Pharmacy Chain Co., Ltd. (603939)
Category
Healthcare
Revenue for Yifeng Pharmacy Chain Co., Ltd. (603939)
Revenue in Jun 2026 TTM: $3.60B
According to Yifeng Pharmacy Chain Co., Ltd. latest financial reports the company's current revenue (TTM) is $3.60B. In 2023 the company made a revenue of $3.19B an increase over the revenue in the year 2022 that was $2.88B. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Yifeng Pharmacy Chain Co., Ltd. from 2011 to 2026
Revenue at the end of each year
| Year | Revenue | Change |
|---|---|---|
| 2026 (TTM) | $3.60B | 9.20% |
| 2024 | $3.30B | 3.31% |
| 2023 | $3.19B | 10.69% |
| 2022 | $2.88B | 19.56% |
| 2021 | $2.41B | 19.84% |
| 2020 | $2.01B | 36.34% |
| 2019 | $1.48B | 46.85% |
| 2018 | $1.00B | 36.01% |
| 2017 | $738.87M | 37.40% |
| 2016 | $537.76M | 22.72% |
| 2015 | $438.19M | 21.70% |
| 2014 | $360.06M | 21.05% |
| 2013 | $297.46M | 20.49% |
| 2012 | $246.88M | 27.14% |
| 2011 | $194.18M | 0.00% |
Revenue for similar companies or competitors
| Company | Revenue | Revenue Difference | Country |
|---|---|---|---|
| $2.54B | -29.55% |
US
|
|
| - | - |
SE
|
|
| - | - |
FR
|
|
| $830.81M | -76.92% |
US
|
|
| - | - |
IT
|
